Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

Population-based study of the effectiveness of combined LAMA / LABA versus LABA / ICS therapy as maintenance treatment in COPD patients in primary care.

  • Principal investigators: Mònica Monteagudo Zaragoza
  • Code: 4R21/026
  • Start year: 2021
  • Funders: Boehringer Ingelheim España, S.A.

Incidencia y factores de riesgo de la Covid-19 en pacientes respiratorios crónicos

  • Principal investigators: Mònica Monteagudo Zaragoza
  • Code: 4R21/053
  • Start year: 2021
  • Funders: Institut d’Investigació en Atenció Primària Jordi Gol i Gurina (IDIAPJGol)

Mapatge i monitoratge de la prescripció d’antibiòtics a nivell de la Gerència Territorial Metropolitana Sud.

  • Principal investigators: Mònica Monteagudo Zaragoza, Gemma Rodríguez Palomar
  • Code: 4RNC-0-00204-23
  • Start year: 2023

Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/037
  • Start year: 2021
  • Funders: Fondazione Penta ETS

Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (WP3)

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4R21/065
  • Start year: 2021
  • Funders: Vaccine Monitoring Collaboration for Europe (VAC4EU)